Prg Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 17-07-2024
- Paid Up Capital ₹ 0.11 M
as on 17-07-2024
- Company Age 22 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 49.83%
(FY 2023)
- Profit 100.31%
(FY 2023)
- Ebitda 101.71%
(FY 2023)
- Net Worth 135.06%
(FY 2023)
- Total Assets 149.42%
(FY 2023)
About Prg Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Manish Goel, Brijesh Sharma, and Ankush Pandey serve as directors at the Company.
- CIN/LLPIN
U51397CH2002PTC025353
- Company No.
025353
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
21 Aug 2002
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Prg Pharma Private Limited offer?
Prg Pharma Private Limited offers a wide range of products and services, including Digestive System Drugs & Medicines, Antacid Drugs, Common Disease Medicines, Pharmaceutical Medicine.
Who are the key members and board of directors at Prg Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Goel  | Director | 02-Mar-2007 | Current |
| Brijesh Sharma | Director | 01-Mar-2021 | Current |
| Ankush Pandey | Director | 01-Sep-2021 | Current |
Financial Performance of Prg Pharma.
Prg Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 49.83% increase. The company also saw a substantial improvement in profitability, with a 100.31% increase in profit. The company's net worth Soared by an impressive increase of 135.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prg Pharma?
In 2023, Prg Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prg Pharma?
Prg Pharma has a workforce of 1 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prg Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prg Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
